Search Jobs

Search by job, company or skills

Executive, Regulatory Affairs

Executive, Regulatory Affairs

Amneal Pharmaceuticals

This job is no longer accepting applications

Job Description

Job Description

  • Good knowledge of ANDA submission activities and post-approval procedures and related ICH and USFDA guidelines.
  • Exposure of the Solid oral dosage form / Sterile dosage form / complex dosage form / topical-Inhalation dosage form and brief manufacturing process and key regulatory aspects.
  • Ability to preliminary review the change cases with respect to ICH quality / post approval USFDA guidance and aware for Post approval submission guideline and procedure for Annual report/CBE 0/CBE 30 and PAS filling
  • Drafting of the Annual Report with required submission data as per USFDA guidance.
  • Preliminary review of entire submission package.
  • Awareness about the FDA recommendation on the commercial marketing status notification submission in terms of content and time frames and submissions.
  • Coordination with Cross Functional teams for the documents availability as per regulatory submission plan.
  • Ensure the no delay in drafting and compiling the regulatory submission.
  • Maintain regulatory information as per allocated task.
  • Having good Regulatory CTD modules drafting & preliminary review skills.

Education

QUALIFICATIONS

  • B. Pharm B. Pharm - Required
  • M. Pharm M. Pharm - Preferred

Experience:

  • 5 years or more in 5 - 8 Years

Specialized Knowledge: Licenses:

More Info

Job Type:
Industry:
Employment Type:

Key Skills

post-approval procedures

Sterile dosage form

Solid oral dosage form

Regulatory CTD modules drafting

topical-Inhalation dosage form

complex dosage form

ANDA submission activities

regulatory aspects

USFDA guidelines

Similar Jobs

5-8 yrs
Ahmedabad, India
Skills:
post-approval procedures, Solid oral dosage form, Regulatory CTD modules drafting, topical-Inhalation dosage form, regulatory aspects, CBE 30, USFDA guidelines, Sterile dosage form, DMF Change Notification review, ANDA submission activities, CBE 0, complex dosage form, Manufacturing Process